These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 9067778)
1. Development of differential cytotoxic compounds containing nitrosourea and benzothiazine nucleus. Nyati MK; Rai D; Gupta RR; Dev PK In Vivo; 1997; 11(1):95-9. PubMed ID: 9067778 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of ethylnitrosoureas of substituted naphthalimides as anticancer compounds. Pain A; Samanta S; Dutta S; Saxena AK; Shanmugavel M; Sharma M; Qazi GN; Sanyal U Acta Pol Pharm; 2007; 64(1):27-33. PubMed ID: 17665847 [TBL] [Abstract][Full Text] [Related]
3. Antitumor 2-(aminocarbonyl)-1,2-bis(methylsulfonyl)-1-(2-chloroethyl)- hydrazines. Shyam K; Penketh PG; Loomis RH; Rose WC; Sartorelli AC J Med Chem; 1996 Feb; 39(3):796-801. PubMed ID: 8576923 [TBL] [Abstract][Full Text] [Related]
4. [Effect of N-methyl-N-nitrosourea on the synthesis and processing of RNA in Ehrlich ascitic carcinoma and leukemia L1210 cells]. Dederer LIu; Kukushkina GV; Gorbacheva LB Dokl Akad Nauk SSSR; 1975; 221(3):736-9. PubMed ID: 1120464 [No Abstract] [Full Text] [Related]
5. Pt-ATP as an antineoplastic agent in an experimental mice model system. Pal S; Mukherjea K; Bhattacharya R; Maity P J Exp Clin Cancer Res; 1997 Sep; 16(3):255-60. PubMed ID: 9387898 [TBL] [Abstract][Full Text] [Related]
6. Comparison of new nitrosoureas esters with modified steroidal nucleus for cytogenetic and antineoplastic activity. Hussein A; Mioglou-Kalouptsi E; Papageorgiou A; Karapidaki I; Iakovidou-Kritsi Z; Lialiaris T; Xrysogelou E; Camoutsis C; Mourelatos D In Vivo; 2007; 21(2):389-95. PubMed ID: 17436593 [TBL] [Abstract][Full Text] [Related]
7. Nucleoside analogues. 13. The effect on anti-tumour activity of varying the uracil 5-substituent and the point of attachment (N1 or N3) of the uracil moiety in seco-nucleoside nitrosoureas. Bibby MC; Double JA; McCormick JE; McElhinney RS; Radacic M; Pratesi G; Dumont P Anticancer Drug Des; 1993 Apr; 8(2):115-28. PubMed ID: 8494602 [TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity. Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of dimethoxydop-NU as a novel anti-tumor agent. Mukherjee A; Dutta S; Sanyal U J Exp Clin Cancer Res; 2007 Dec; 26(4):489-97. PubMed ID: 18365543 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of phthalmustine, a new anticancer compound. II. Tumor inhibitory effect in murine Ehrlich ascites carcinoma and sarcoma-180. Bhattacharya S; Ghosh M; Sadhu U; Dutta S; Sanyal U Neoplasma; 1996; 43(3):209-13. PubMed ID: 8841510 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of 2-chloroethylnitrosoureas of substituted naphthalimides as mixed-function anticancer compounds. Samanta S; Pain A; Dutta S; Sanyal U Acta Pol Pharm; 2001; 58(5):351-6. PubMed ID: 11876442 [TBL] [Abstract][Full Text] [Related]
12. Novel modified steroid derivatives of androstanolone as chemotherapeutic anti-cancer agents. El-Far M; Elmegeed GA; Eskander EF; Rady HM; Tantawy MA Eur J Med Chem; 2009 Oct; 44(10):3936-46. PubMed ID: 19447526 [TBL] [Abstract][Full Text] [Related]
13. Cytotoxic effects of the Viscum album L. extract on Ehrlich tumour cells in vivo. Cebović T; Spasić S; Popović M Phytother Res; 2008 Aug; 22(8):1097-103. PubMed ID: 18570233 [TBL] [Abstract][Full Text] [Related]
14. [The dose-dependent cytogenetic and growth-inhibiting effects of a new antitumor preparation from the nitrosourea group]. Fomina MM; Dzhamanbaev ZhA; Ostrovskaia LA Izv Akad Nauk SSSR Biol; 1991; (3):436-44. PubMed ID: 1955617 [TBL] [Abstract][Full Text] [Related]
15. [Antitumor effects of organic silicone compounds (IV). Antitumor effects of SDK-50 and SDK-47]. Toyoshima S; Fukushima K; Sakurai T; Sugimoto Y; Sato H; Taguchi H Gan To Kagaku Ryoho; 1982 Feb; 9(2):225-9. PubMed ID: 7184399 [TBL] [Abstract][Full Text] [Related]
16. The influence of three newly synthesized pyrimidine-containing compounds on micronucleus induction and tumor growth. Nersesyan A; Muradyan R; Arsenyan F J BUON; 2007; 12(4):521-7. PubMed ID: 18067211 [TBL] [Abstract][Full Text] [Related]
17. Effect of lysolecithin and analogs on mouse ascites tumors. Tarnowski GS; Mountain IM; Stock CC; Munder PG; Weltzien HU; Westphal O Cancer Res; 1978 Feb; 38(2):339-44. PubMed ID: 620405 [No Abstract] [Full Text] [Related]
18. [Toxicity and antitumoral activity of two new complex compounds of rhenium]. Natorkhin MI; Stukov AN; Filov VA Vopr Onkol; 2002; 48(1):61-2. PubMed ID: 12101569 [TBL] [Abstract][Full Text] [Related]
19. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models. Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, antitumor evaluation, molecular modeling and quantitative structure-activity relationship (QSAR) of some novel arylazopyrazolodiazine and triazine analogs. El-Shafei A; Fadda AA; Khalil AM; Ameen TA; Badria FA Bioorg Med Chem; 2009 Jul; 17(14):5096-105. PubMed ID: 19527933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]